IDO1 and neoplasm: The miR-143 expression and the regulation of T-cell differentiation are suppressed by IDO and its metabolite, kynurenine, in the tumor microenvironment, so IDO inhibition in the TME might increase the expression of miR-143 and enhance the antitumor effects of T cells by promoting T-cell differentiation [88].